ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

DOXORUBICINUM

Active substance (INN) · ATC L01DB01 · 5 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
L004C	BEVACIZUMABUM	In force	mentioned in the text	C2-P3	NO
L01CX01	TRABECTEDINUM	In force	mentioned in the text	C2-P3	NO
L01XC12	BRENTUXIMAB VEDOTIN	In force	mentioned in the text	C2-P3	NO
L01XC15	OBINUTUZUMAB	In force	mentioned in the text	C2-P3	NO
L01XC37	POLATUZUMAB VEDOTIN	In force	mentioned in the text	C2-P3	NO
L01XE27	IBRUTINIBUM	In force	mentioned in the text	C2-P3	NO
L026C	TRASTUZUMABUM	In force	mentioned in the text	C2-P3	NO
L050C	INTERFERONUM ALFA 2A	In force	mentioned in the text	C2-P3	NO

History: entries into and exits from protocols

Month	Type	Code	Protocol	Level
March 2026	Medicine added	L01XE27	IBRUTINIBUM	mentioned in the text

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
CAELYX PEGYLATED LIPOSOMAL 2 mg/ml	CONC. PT. SOL. PERF.	2mg/ml	BAXTER HOLDING B.V. - OLANDA	L01DB01	S
DOXLOX 2 mg/ml	CONC. PT. DISPERSIE PERF.	2 mg/ml	DR. REDDY'S LABORATORIES ROMANIA S.R.L. - ROMANIA	L01DB01	PR
DOXORUBICINA ACCORD 2 mg/ml	CONC. PT. SOL. PERF.	2mg/ml	ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA	L01DB01	PR
MYOCET LIPOSOMAL 50 mg	PULB.+AMESTC. PT. CONC. PT.DISP.LIPOZOM.PT.PERF.	50mg	CHEPLAPHARM ARZNEIMITTEL GMBH - GERMANIA	L01DB01	PR
ZOLSKETIL PEGYLATED LIPOSOMAL 2 mg/ml	CONC. PT. DISPERSIE PERF.	2mg/ml	ACCORD HEALTHCARE S.L.U. - SPANIA	L01DB01	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.